July 14, 2023
An investor in bioelectronic medicine company electroCore Inc. will have one final shot at revising her proposed class action alleging that the company misrepresented the types and scope of agreements the company had in place with commercial health insurance companies in the lead-up to its $77.7 million initial public offering in June 2018, a New Jersey federal judge has decided.